Scinai Immunotherapeutics (SCNI) Balance Sheet: Assets & Liabilities

Scinai Immunotherapeutics (SCNI) Balance Sheet

As of Dec 31, 2025 (end of fiscal 2025), Scinai Immunotherapeutics reported total assets of $11.63M and total liabilities of $3.52M. Shareholders' equity was $8.10M, down 18.8% from $9.98M a year earlier. Total debt stood at $623.00K against $1.66M in cash and short-term investments, a net cash position of $1.04M. That puts debt-to-equity at 0.08, compared with 0.21 a year earlier.

Scinai Immunotherapeutics Balance Sheet Analysis

Values in billions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Scinai Immunotherapeutics Ltd. (SCNI) - Annual data in billions USD
Breakdown	FY 2025	FY 2024	FY 2024	FY 2023	FY 2022	FY 2022	FY 2021	FY 2020	FY 2020	FY 2019	FY 2018	FY 2017
Period ending	Dec 2025	Mar 2025	Dec 2024	Dec 2023	Mar 2023	Dec 2022	Dec 2021	Mar 2021	Dec 2020	Mar 2020	Mar 2019	Dec 2017
Current Assets
Cash and Cash Equivalents	0.00	0.00	0.00	0.00	0.01	0.01	0.02	0.00	0.00	0.02	0.02	0.02
Cash & Short-Term Investments	0.00	0.00	0.00	0.00	0.01	0.01	0.02	0.00	0.00	0.02	0.02	0.02
Accounts Receivable	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Inventory	0.00	0.00	-	0.00	0.00	-	0.00	0.00	-	0.00	0.00	0.00
Other Current Assets	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Current Assets	0.00	0.00	0.00	0.01	0.01	0.01	0.02	0.00	0.00	0.02	0.02	0.02
Non-Current Assets
Property, Plant & Equipment (Net)	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.00
Long-Term Investments	0.00	0.00	-	0.00	0.00	-	0.00	0.00	-	0.00	0.00	0.00
Other Non-Current Assets	0.00	0.00	-	0.00	0.00	-	0.00	0.00	0.00	0.00	0.00	0.00
Total Non-Current Assets	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	-	0.01	0.01	0.00
Total Assets	0.01	0.01	0.01	0.02	0.03	0.03	0.03	0.02	0.02	0.03	0.03	0.02
Current Liabilities
Accounts Payable	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.01	0.00
Short-Term Debt	0.00	0.00	-	0.00	0.00	-	0.00	0.02	0.02	0.00	0.00	0.00
Current Portion of Long-Term Debt	-	-	-	-	-	-	-	-	0.02	-	-	-
Accrued Liabilities	0.00	-	0.00	0.00	-	0.00	0.00	-	0.00	-	-	-
Deferred Revenue	0.00	0.00	0.00	0.00	0.00	-	0.00	0.00	-	0.00	0.00	0.00
Other Current Liabilities	0.00	0.00	-	0.00	0.00	-	0.00	0.00	-	0.00	0.00	0.00
Total Current Liabilities	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.02	0.02	0.01	0.01	0.00
Non-Current Liabilities
Long-Term Debt	0.00	0.00	0.00	0.02	0.02	0.02	0.03	0.00	-	0.04	0.03	0.00
Other Non-Current Liabilities	0.00	0.00	0.00	0.00	0.01	0.01	0.00	0.00	0.00	0.01	0.01	0.01
Total Non-Current Liabilities	0.00	0.00	0.00	0.02	0.03	0.03	0.03	0.00	-	0.05	0.03	0.01
Total Liabilities	0.00	0.00	0.00	0.02	0.03	0.03	0.03	0.02	0.02	0.05	0.04	0.01
Stockholders' Equity
Retained Earnings	-0.13	-0.12	-0.12	-0.12	-0.12	-0.12	-0.11	-0.10	-0.10	-0.09	-0.06	-0.04
Accumulated Other Comprehensive Income	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-	0.00	0.00	0.00
Additional Paid-in Capital	0.13	0.12	0.12	0.12	0.12	0.12	0.11	0.10	-	0.07	0.05	0.05
Shares Outstanding	13.87	-	3.41	1.86	-	0.99	0.74	-	-	-	-	-
Total Stockholders' Equity	0.01	0.01	0.01	0.00	0.00	0.00	0.00	0.00	0.00	-0.02	-0.01	0.02
Total Liabilities & Equity	0.01	0.01	0.01	0.02	0.03	0.03	0.03	0.02	-	0.03	0.03	0.02

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Scinai Immunotherapeutics Balance Sheet

How much debt does Scinai Immunotherapeutics have?

Scinai Immunotherapeutics had total debt of $623.00K as of Dec 31, 2025, against $1.66M in cash and short-term investments. Its debt-to-equity ratio was 0.08. Total debt was $2.09M a year earlier.

What are Scinai Immunotherapeutics's total assets?

Scinai Immunotherapeutics reported total assets of $11.63M as of Dec 31, 2025, down 13.5% from $13.45M a year earlier. Total liabilities were $3.52M.

What is Scinai Immunotherapeutics's shareholders' equity?

Scinai Immunotherapeutics's shareholders' equity was $8.10M as of Dec 31, 2025, or about $0.00 of book value per share.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition